Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

VCNX Financial Statements and Analysis

NASDAQ : VCNX

Vaccinex, Inc.

$0.55
0.1406+34.34%
At Close 4:00 PM
59.9
BESG ScoreESG Rating

VCNX FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

VCNX Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue52.00K232.00K104.00K-386.00K20.00K
cost of revenue03.864M27.00K26.50K31.00K
gross profit52.00K-3.632M77.00K-412.50K-11.00K
gross profit ratio1.00-15.6550.741.069-0.55
research and development expenses3.165M3.864M3.383M3.331M4.355M
general and administrative expenses1.439M2.09M1.795M1.631M1.499M
selling and marketing expenses0-1.00000
selling general and administrative expenses1.439M2.09M1.795M1.631M1.499M
other expenses00-1.00K-52.00K922.00K
operating expenses4.604M5.954M5.178M4.962M5.854M
cost and expenses4.604M5.954M5.178M4.988M5.854M
interest income00000
interest expense0028.00K383.00K0
depreciation and amortization24.00K25.00K27.00K26.50K31.00K
ebitda-5.708M-5.606M-3.842M-4.962M-5.834M
ebitda ratio-109.769-24.164-48.78812.854-291.70
operating income-4.552M-5.722M-5.074M-4.988M-5.834M
operating income ratio-87.538-24.664-48.78812.922-291.70
total other income expenses net-1.18M91.00K1.177M1.671M922.00K
income before tax-5.732M-5.631M-3.897M-3.317M-4.912M
income before tax ratio-110.231-24.272-37.4718.593-245.60
income tax expense00-27.00K38.00K-31.00K
net income-5.732M-5.631M-3.897M-3.317M-4.912M
net income ratio-110.231-24.272-37.4718.593-245.60
eps-2.83-3.10-2.94-3.72-15.26
eps diluted-2.83-3.10-2.94-3.72-15.26
weighted average shs out2.027M1.818M1.327M892.611K321.916K
weighted average shs out dil2.027M1.818M1.327M892.611K321.916K
Graph

VCNX Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents2.906M233.00K2.972M1.535M127.00K
short term investments00000
cash and short term investments2.906M233.00K2.972M1.535M127.00K
net receivables985.00K1.045M2.775M961.00K933.00K
inventory00000
other current assets866.00K924.00K1.407M853.00K1.146M
total current assets4.757M2.202M7.154M3.349M2.206M
property plant equipment net97.00K165.00K213.00K282.00K352.00K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets000-1.000
total non current assets97.00K165.00K213.00K281.999K352.00K
other assets0001.000
total assets4.854M2.367M7.367M3.631M2.558M
account payables4.865M3.243M2.329M2.039M4.225M
short term debt59.00K181.00K179.00K221.00K242.00K
tax payables00000
deferred revenue51.00K12.00K59.00K63.00K0
other current liabilities1.20M1.795M2.139M3.593M1.895M
total current liabilities6.175M5.231M4.706M5.916M6.362M
long term debt006.00K26.00K65.00K
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities000-1.000
total non current liabilities006.00K25.999K65.00K
other liabilities0001.000
capital lease obligations15.00K59.00K103.00K146.00K188.00K
total liabilities6.175M5.231M4.712M5.942M6.427M
preferred stock1.522M1.379M1.236M00
common stock1.00K1.00K1.00K00
retained earnings-355.187M-349.455M-343.824M-339.927M-336.61M
accumulated other comprehensive income loss0-1.379M-1.236M00
other total stockholders equity352.343M346.59M345.242M337.616M332.752M
total stockholders equity-1.321M-2.864M2.655M-2.311M-3.869M
total equity-1.321M-2.864M2.655M-2.311M-3.869M
total liabilities and stockholders equity4.854M2.367M7.367M3.631M2.558M
minority interest00000
total investments00000
total debt59.00K122.00K185.00K247.00K307.00K
net debt-2.847M-111.00K-2.787M-1.288M180.00K
Graph

VCNX Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateJun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-2.371M115.00K419.00K
stock based compensation112.00K96.00K104.00K115.00K126.00K
change in working capital1.153M348.00K-2.512M1.671M1.397M
accounts receivables-20.00K-64.00K-28.00K-922.00K-11.00K
inventory00000
accounts payables906.00K290.00K-2.186M2.617M515.00K
other working capital267.00K122.00K-298.00K-24.00K893.00K
other non cash items-798.00K-1.282M4.478M-115.00K-419.00K
net cash provided by operating activities-4.415M-4.632M-3.592M-3.095M-5.507M
investments in property plant and equipment-14.00K00-18.00K0
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites-14.00K00-18.00K0
debt repayment-7.00K-19.00K-17.00K-19.00K-19.00K
common stock issued1.697M6.088M5.017M1.351M4.111M
common stock repurchased00000
dividends paid00000
other financing activites1.697M3.54M004.092M
net cash used provided by financing activities1.69M6.069M5.00M1.332M4.092M
effect of forex changes on cash0001.896M0
net change in cash-2.739M1.437M1.408M-1.781M-1.415M
cash at end of period233.00K2.972M1.535M127.00K1.908M
cash at beginning of period2.972M1.535M127.00K1.908M3.323M
operating cashflow-4.415M-4.632M-3.592M-3.095M-5.507M
capital expenditure-14.00K00-18.00K0
free cash flow-4.429M-4.632M-3.592M-3.113M-5.507M
Graph

Frequently Asked Questions

How did Vaccinex, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, VCNX generated $52.00K in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did Vaccinex, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Vaccinex, Inc. reported a $52.00K Gross Profit for the quarter ended Jun 30, 2024.
Have VCNX's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. VCNX incurred $4.60M worth of Operating Expenses, while it generated -$4.55M worth of Operating Income.
How much Net Income has VCNX posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Vaccinex, Inc., the company generated -$5.73M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Vaccinex, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Vaccinex, Inc. as of the end of the last quarter was $2.91M.
What are VCNX's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, VCNX had Total Net Receivables of $985.00K.
In terms of Total Assets and Current Assets, where did Vaccinex, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of VCNX were $4.76M, while the Total Assets stand at $4.85M.
As of the last quarter, how much Total Debt did Vaccinex, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of VCNX's debt was $59.00K at the end of the last quarter.
What were VCNX's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, VCNX reported total liabilities of $6.18M.
How much did VCNX's Working Capital change over the last quarter?
Working Capital Change for VCNX was $1.15M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
VCNX generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. VCNX generated -$4.42M of Cash from Operating Activities during its recently reported quarter.
What was VCNX's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. VCNX reported a -$2.74M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph